<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Takeda's Dengue Shot is 80% Effective in Phase III Trial
Image Overlay - Takeda's Dengue Shot is 80% Effective in Phase III Trial

Takeda's Dengue Shot is 80% Effective in Phase III Trial

November 28, 2019

Takeda's Dengue Shot is 80% Effective in Phase III Trial

Takeda has released results from a clinical trial that found its dengue shot was 95.4% effective in preventing dengue that required hospitalization; there were five hospitalizations in the vaccine group versus 53 in the placebo group. The company will submit these phase III results for regulatory approval. With clinical trials taking place in more than 200 countries worldwide, Yourway is the partner that companies need to navigate the diverse and ever-changing global regulatory landscape.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat
Come chat with us!
Hello! How can I help you?